{"title":"美国生物仿制药市场的未来趋势","authors":"G. Barkha, K. Praneeth","doi":"10.4172/2153-2435.1000543","DOIUrl":null,"url":null,"abstract":"USA is a largest market of biologics globally. Biosimilar market expected to represent CAGR of 62.2 % as the chances of growth of biosimilar market from $1.7 billion in 2014 to $30 billion by 2020. Currently USA is a very small market for biosimilar but it can grow as the largest contributor for biosimilars as major share (upto 10 %) of the global revenue is generated from USA. Biosimilar therapy is a very effective way of treating disease conditions like cancer, rheumatoid, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis and many autoimmune disorders [1].","PeriodicalId":19833,"journal":{"name":"Pharmaceutica Analytica Acta","volume":"663 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2017-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biosimilar Drugs Market Future Trends in United States\",\"authors\":\"G. Barkha, K. Praneeth\",\"doi\":\"10.4172/2153-2435.1000543\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"USA is a largest market of biologics globally. Biosimilar market expected to represent CAGR of 62.2 % as the chances of growth of biosimilar market from $1.7 billion in 2014 to $30 billion by 2020. Currently USA is a very small market for biosimilar but it can grow as the largest contributor for biosimilars as major share (upto 10 %) of the global revenue is generated from USA. Biosimilar therapy is a very effective way of treating disease conditions like cancer, rheumatoid, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis and many autoimmune disorders [1].\",\"PeriodicalId\":19833,\"journal\":{\"name\":\"Pharmaceutica Analytica Acta\",\"volume\":\"663 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-04-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutica Analytica Acta\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2153-2435.1000543\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutica Analytica Acta","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2153-2435.1000543","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Biosimilar Drugs Market Future Trends in United States
USA is a largest market of biologics globally. Biosimilar market expected to represent CAGR of 62.2 % as the chances of growth of biosimilar market from $1.7 billion in 2014 to $30 billion by 2020. Currently USA is a very small market for biosimilar but it can grow as the largest contributor for biosimilars as major share (upto 10 %) of the global revenue is generated from USA. Biosimilar therapy is a very effective way of treating disease conditions like cancer, rheumatoid, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis and many autoimmune disorders [1].
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
